Cargando…

Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients

Mutations in BRCA1 and BRCA2 genes predispose to breast and ovarian cancer (BC/OC) with a high lifetime risk, whereas mutations in PALB2, CHEK2, ATM, FANCM, RAD51C and RAD51D genes cause a moderately elevated risk. In the Finnish population, recurrent mutations have been identified in all of these g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nurmi, Anna, Muranen, Taru A., Pelttari, Liisa M., Kiiski, Johanna I., Heikkinen, Tuomas, Lehto, Sini, Kallioniemi, Anne, Schleutker, Johanna, Bützow, Ralf, Blomqvist, Carl, Aittomäki, Kristiina, Nevanlinna, Heli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Cancer Genetics and Epigenetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767104/ https://www.ncbi.nlm.nih.gov/pubmed/30927251 http://dx.doi.org/10.1002/ijc.32309

Ejemplares similares

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families
por: Pelttari, Liisa M, et al.
Publicado: (2015)

FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population
por: Kiiski, Johanna I., et al.
Publicado: (2017)

FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome
por: Kiiski, Johanna I., et al.
Publicado: (2016)

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
por: Muranen, Taru A., et al.
Publicado: (2016)

NTHL1 is a recessive cancer susceptibility gene
por: Nurmi, Anna K., et al.
Publicado: (2023)

Variants on the promoter region of PTEN affect breast cancer progression and patient survival
por: Heikkinen, Tuomas, et al.
Publicado: (2011)

Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients
por: Pelttari, Liisa M, et al.
Publicado: (2012)

Pathogenic Variant Spectrum in Breast Cancer Risk Genes in Finnish Patients
por: Nurmi, Anna K., et al.
Publicado: (2022)

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
por: Hallamies, Sanna, et al.
Publicado: (2017)

High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome
por: Jamshidi, Maral, et al.
Publicado: (2021)

MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer
por: Peurala, Hanna, et al.
Publicado: (2011)

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
por: Muranen, Taru A, et al.
Publicado: (2011)

Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility
por: Mantere, Tuomo, et al.
Publicado: (2017)

Comprehensive analysis of NuMA variation in breast cancer
por: Kilpivaara, Outi, et al.
Publicado: (2008)

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

ANO7 is associated with aggressive prostate cancer
por: Kaikkonen, Elina, et al.
Publicado: (2018)

ATM variants and cancer risk in breast cancer patients from Southern Finland
por: Tommiska, Johanna, et al.
Publicado: (2006)

Clinical features and spectrum of NOTCH3 variants in Finnish patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
por: Mönkäre, Saana, et al.
Publicado: (2022)

Effect of Disease Severity on Comorbid Conditions in Atopic Dermatitis: Nationwide Registry-Based Investigation in Finnish Adults
por: KIISKI, Ville, et al.
Publicado: (2023)

A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients
por: Wendt, Camilla, et al.
Publicado: (2021)

Maritime sector at verge of change: learning and competence needs in Finnish maritime cluster
por: Kilpi, Vesa, et al.
Publicado: (2021)

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2008)

Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer
por: Khan, Sofia, et al.
Publicado: (2017)

Data Integration Workflow for Search of Disease Driving Genes and Genetic Variants
por: Karinen, Sirkku, et al.
Publicado: (2011)

Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility
por: Low, Yen Ling, et al.
Publicado: (2010)

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer
por: Alhopuro, Pia, et al.
Publicado: (2020)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families
por: Fischer, Daniel, et al.
Publicado: (2015)

Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
por: Li, Yuqing, et al.
Publicado: (2011)

PALB2 variants in hereditary and unselected Finnish Prostate cancer cases
por: Pakkanen, Sanna, et al.
Publicado: (2009)

BACH1 Ser919Pro variant and breast cancer risk
por: Vahteristo, Pia, et al.
Publicado: (2006)

Germline TP53 mutations in Finnish breast cancer patients
por: Rapakko, K, et al.
Publicado: (2000)

Dietary Heavy Metal Exposure among Finnish Adults in 2007 and in 2012
por: Suomi, Johanna, et al.
Publicado: (2021)

Identification of genetic markers with synergistic survival effect in cancer
por: Louhimo, Riku, et al.
Publicado: (2013)

The association between night shift work and breast cancer risk in the Finnish twins cohort
por: Schernhammer, Eva, et al.
Publicado: (2023)

TARDBP mutations are not a frequent cause of ALS in Finnish patients
por: MENTULA, HANNA-KAISA, et al.
Publicado: (2012)

A Genome Wide Meta-Analysis Study for Identification of Common Variation Associated with Breast Cancer Prognosis
por: Rafiq, Sajjad, et al.
Publicado: (2014)

Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
por: Arason, Adalgeir, et al.
Publicado: (2010)

Copy Number Variation Analysis in Familial BRCA1/2-Negative Finnish Breast and Ovarian Cancer
por: Kuusisto, Kirsi M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v6nihks3cevcgckpb3qk1o74ks